Biosynex SA (EPA:ALBIO)

Biosynex Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	8.46	4.69	20.17	87.17	132.03
Short-Term Investments	-	5	6	-	-
Cash & Short-Term Investments	8.46	9.69	26.16	87.17	132.03
Cash Growth	-12.75%	-62.96%	-69.99%	-33.98%	258.43%
Accounts Receivable	7.82	7.1	10.65	14.7	25.27
Other Receivables	12.68	6.81	5.84	14.09	6.08
Receivables	20.49	13.91	16.49	28.79	31.35
Inventory	22.87	32.67	38.21	37.67	31.15
Prepaid Expenses	1.54	1.91	-	1.43	1.05
Other Current Assets	2.04	1.66	4.83	3.35	2.27
Total Current Assets	55.56	64.39	91.35	159.61	198.78
Property, Plant & Equipment	8.5	11.82	11.94	6.38	3.44
Long-Term Investments	0.37	0.6	0.47	2.57	3.28
Goodwill	-	64.13	91.54	60.91	46.24
Other Intangible Assets	69.24	20.71	21.76	25.95	5.89
Long-Term Deferred Charges	-	28.11	16.36	-	-
Other Long-Term Assets	2.56	4.92	8.3	4.93	11.31
Total Assets	136.24	194.69	241.73	260.34	268.94

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	17.15	16.31	15.07	14.99	18.73
Accrued Expenses	6	4.92	6.19	6.62	7.64
Short-Term Debt	-	-	0.24	0.04	0.04
Current Portion of Long-Term Debt	60.8	-	-	49.48	0.15
Current Portion of Leases	0.46	-	-	1.41	-
Current Income Taxes Payable	2.86	5.14	0.01	1.73	19.81
Current Unearned Revenue	0.14	0.22	0.51	0.22	1.94
Other Current Liabilities	0.02	-	9.17	8.36	12.45
Total Current Liabilities	87.42	26.6	31.19	83.86	61.32
Long-Term Debt	-	62.63	63.88	1.15	34.08
Long-Term Leases	0.39	-	1.84	-	1.04
Long-Term Deferred Tax Liabilities	1.13	6.6	3.48	-	-
Other Long-Term Liabilities	10.42	14.56	17.02	8.43	4.69
Total Liabilities	99.35	110.38	117.41	93.45	101.14

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1.88	1.08	1.08	1.03	1.11
Additional Paid-In Capital	32.78	25.6	25.6	25.6	47.27
Retained Earnings	-58.22	-43.33	55.31	77.08	130.92
Comprehensive Income & Other	60.45	101.06	42.49	58.83	-11.5
Total Common Equity	36.89	84.4	124.48	162.53	167.81
Minority Interest	-	-0.08	-0.17	4.37	-
Shareholders' Equity	36.89	84.31	124.32	166.9	167.81
Total Liabilities & Equity	136.24	194.69	241.73	260.34	268.94

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	61.65	62.63	65.96	52.08	35.31
Net Cash (Debt)	-53.19	-52.94	-39.8	35.1	96.72
Net Cash Growth	-	-	-	-63.71%	359.13%
Net Cash Per Share	-2.89	-4.92	-3.72	3.41	9.31
Filing Date Shares Outstanding	18.43	18.75	10.76	10.25	10.32
Total Common Shares Outstanding	18.43	10.76	10.76	10.25	10.32
Working Capital	-31.86	37.8	60.16	75.75	137.45
Book Value Per Share	2.00	7.84	11.57	15.85	16.26
Tangible Book Value	-32.35	-0.45	11.18	75.67	115.67
Tangible Book Value Per Share	-1.76	-0.04	1.04	7.38	11.21
Buildings	-	3.87	3.13	-	-
Machinery	-	24.48	31.4	10.58	6.37
Construction In Progress	-	0	0.02	0.03	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 20, 2026

Data Sources Report a data error